|
US7157277B2
(en)
|
2001-11-28 |
2007-01-02 |
Neose Technologies, Inc. |
Factor VIII remodeling and glycoconjugation of Factor VIII
|
|
US7173003B2
(en)
|
2001-10-10 |
2007-02-06 |
Neose Technologies, Inc. |
Granulocyte colony stimulating factor: remodeling and glycoconjugation of G-CSF
|
|
US7214660B2
(en)
|
2001-10-10 |
2007-05-08 |
Neose Technologies, Inc. |
Erythropoietin: remodeling and glycoconjugation of erythropoietin
|
|
US8791070B2
(en)
|
2003-04-09 |
2014-07-29 |
Novo Nordisk A/S |
Glycopegylated factor IX
|
|
WO2006127896A2
(en)
|
2005-05-25 |
2006-11-30 |
Neose Technologies, Inc. |
Glycopegylated factor ix
|
|
EP2055189A1
(en)
|
2003-04-09 |
2009-05-06 |
Neose Technologies, Inc. |
Glycopegylation methods and proteins/peptides produced by the methods
|
|
US9005625B2
(en)
|
2003-07-25 |
2015-04-14 |
Novo Nordisk A/S |
Antibody toxin conjugates
|
|
US20080305992A1
(en)
|
2003-11-24 |
2008-12-11 |
Neose Technologies, Inc. |
Glycopegylated erythropoietin
|
|
US20060040856A1
(en)
|
2003-12-03 |
2006-02-23 |
Neose Technologies, Inc. |
Glycopegylated factor IX
|
|
WO2005058954A1
(en)
*
|
2003-12-18 |
2005-06-30 |
Novo Nordisk A/S |
Novel glp-1 compounds
|
|
EP1771066A2
(en)
|
2004-07-13 |
2007-04-11 |
Neose Technologies, Inc. |
Branched peg remodeling and glycosylation of glucagon-like peptide-1 glp-1
|
|
ES2566670T3
(es)
|
2004-10-29 |
2016-04-14 |
Ratiopharm Gmbh |
Remodelación y glucopegilación del factor de crecimiento de fibroblastos (FGF)
|
|
MX2007008229A
(es)
|
2005-01-10 |
2007-09-11 |
Neose Technologies Inc |
Factor estimulador de colonias de granulocitos glicopegilado.
|
|
TWI376234B
(en)
|
2005-02-01 |
2012-11-11 |
Msd Oss Bv |
Conjugates of a polypeptide and an oligosaccharide
|
|
AU2006224537A1
(en)
|
2005-03-18 |
2006-09-21 |
Novo Nordisk A/S |
Extended GLP-1 compounds
|
|
TWI362392B
(en)
|
2005-03-18 |
2012-04-21 |
Novo Nordisk As |
Acylated glp-1 compounds
|
|
EP2386571B1
(en)
|
2005-04-08 |
2016-06-01 |
ratiopharm GmbH |
Compositions and methods for the preparation of protease resistant human growth hormone glycosylation mutants
|
|
WO2006121860A2
(en)
*
|
2005-05-06 |
2006-11-16 |
Bayer Pharmaceuticals Corporation |
Glucagon-like peptide 1 (glp-1) receptor agonists and their pharmacological methods of use
|
|
ATE482724T1
(de)
*
|
2005-05-13 |
2010-10-15 |
Lilly Co Eli |
Pegylierte glp-1-verbindungen
|
|
US20070105755A1
(en)
|
2005-10-26 |
2007-05-10 |
Neose Technologies, Inc. |
One pot desialylation and glycopegylation of therapeutic peptides
|
|
WO2007050651A1
(en)
*
|
2005-10-26 |
2007-05-03 |
Eli Lilly And Company |
Selective vpac2 receptor peptide agonists
|
|
WO2007056191A2
(en)
|
2005-11-03 |
2007-05-18 |
Neose Technologies, Inc. |
Nucleotide sugar purification using membranes
|
|
ES2572952T3
(es)
|
2005-11-07 |
2016-06-03 |
Indiana University Research And Technology Corporation |
Análogos de glucagón que muestran solubilidad y estabilidad fisiológicas
|
|
WO2007075534A2
(en)
*
|
2005-12-16 |
2007-07-05 |
Nektar Therapeutics Al, Corporation |
Polymer conjugates of glp-1
|
|
EP2573111A1
(en)
*
|
2006-04-20 |
2013-03-27 |
Amgen Inc. |
GLP-1 compounds
|
|
US9187532B2
(en)
|
2006-07-21 |
2015-11-17 |
Novo Nordisk A/S |
Glycosylation of peptides via O-linked glycosylation sequences
|
|
WO2008057683A2
(en)
|
2006-10-03 |
2008-05-15 |
Novo Nordisk A/S |
Methods for the purification of polypeptide conjugates
|
|
CN102827284B
(zh)
|
2006-11-14 |
2015-07-29 |
上海仁会生物制药股份有限公司 |
带有聚乙二醇基团的Exendin或其类似物及其制剂和用途
|
|
EP2102355B1
(en)
*
|
2006-12-14 |
2016-03-02 |
Bolder Biotechnology, Inc. |
Long acting proteins and peptides and methods of making and using the same
|
|
JP2008169195A
(ja)
*
|
2007-01-05 |
2008-07-24 |
Hanmi Pharmaceutical Co Ltd |
キャリア物質を用いたインスリン分泌ペプチド薬物結合体
|
|
RU2477286C2
(ru)
*
|
2007-01-05 |
2013-03-10 |
Индиана Юниверсити Рисерч Энд Текнолоджи Корпорейшн |
АНАЛОГИ ГЛЮКАГОНА, ОБЛАДАЮЩИЕ ПОВЫШЕННОЙ РАСТВОРИМОСТЬЮ В БУФЕРАХ С ФИЗИОЛОГИЧЕСКИМ ЗНАЧЕНИЕМ pH
|
|
MX2009008241A
(es)
|
2007-02-15 |
2009-10-08 |
Univ Indiana Res & Tech Corp |
Co-agonistas de receptor de glucagon/glp-1.
|
|
EA017770B1
(ru)
|
2007-04-03 |
2013-03-29 |
Биодженерикс Аг |
Способы лечения с использованием гликопэгилированного g-csf
|
|
CN101778859B
(zh)
|
2007-06-12 |
2014-03-26 |
诺和诺德公司 |
改良的用于生产核苷酸糖的方法
|
|
BRPI0813139A8
(pt)
|
2007-06-19 |
2019-01-29 |
Glytech Inc |
peptídeo glp-1 com adição de cadeia oligossacarídea
|
|
WO2009030771A1
(en)
|
2007-09-05 |
2009-03-12 |
Novo Nordisk A/S |
Peptides derivatized with a-b-c-d- and their therapeutical use
|
|
WO2009030738A1
(en)
|
2007-09-05 |
2009-03-12 |
Novo Nordisk A/S |
Glucagon-like peptide-1 derivatives and their pharmaceutical use
|
|
US20100292133A1
(en)
|
2007-09-05 |
2010-11-18 |
Novo Nordisk A/S |
Truncated glp-1 derivaties and their therapeutical use
|
|
ES2509883T3
(es)
|
2007-10-30 |
2014-10-20 |
Indiana University Research And Technology Corporation |
Antagonistas de glucagón
|
|
US8980830B2
(en)
*
|
2007-10-30 |
2015-03-17 |
Indiana University Research And Technology Corporation |
Peptide compounds exhibiting glucagon antagonist and GLP-1 agonist activity
|
|
CA2713348C
(en)
|
2008-01-30 |
2018-10-09 |
Indiana University Research And Technology Corporation |
Ester-based peptide prodrugs
|
|
EP2626080A3
(en)
|
2008-02-27 |
2014-03-05 |
Novo Nordisk A/S |
Conjugated factor VIII molecules
|
|
WO2010011439A2
(en)
|
2008-06-17 |
2010-01-28 |
Indiana University Research And Technology Corporation |
Gip-based mixed agonists for treatment of metabolic disorders and obesity
|
|
AR072160A1
(es)
|
2008-06-17 |
2010-08-11 |
Univ Indiana Res & Tech Corp |
Co-agonistas del receptor de glucagon/glp-1
|
|
WO2009155257A1
(en)
*
|
2008-06-17 |
2009-12-23 |
Indiana University Research And Technology Corporation |
Glucagon analogs exhibiting enhanced solubility and stability physiological ph buffers
|
|
IT1392655B1
(it)
*
|
2008-11-20 |
2012-03-16 |
Bio Ker S R L |
Site-specific monoconjugated insulinotropic glp-1 peptides.
|
|
WO2010080609A1
(en)
|
2008-12-19 |
2010-07-15 |
Indiana University Research And Technology Corporation |
Amide-based insulin prodrugs
|
|
AU2009327418A1
(en)
*
|
2008-12-19 |
2010-06-24 |
Indiana University Research And Technology Corporation |
Amide based glucagon superfamily peptide prodrugs
|
|
KR20110114568A
(ko)
*
|
2008-12-19 |
2011-10-19 |
인디애나 유니버시티 리서치 앤드 테크놀로지 코퍼레이션 |
디펩티드 링크된 약효 물질
|
|
CA2747490C
(en)
|
2008-12-19 |
2017-02-14 |
Indiana University Research And Technology Corporation |
Insulin analogs
|
|
HRP20161055T1
(hr)
|
2009-03-20 |
2016-11-04 |
Hanmi Science Co., Ltd. |
Postupak proizvodnje konjugata specifičnog za mjesto od fiziološki djelotvornog polipeptida
|
|
CN101870728A
(zh)
|
2009-04-23 |
2010-10-27 |
派格生物医药(苏州)有限公司 |
新型Exendin变体及其缀合物
|
|
US9150632B2
(en)
|
2009-06-16 |
2015-10-06 |
Indiana University Research And Technology Corporation |
GIP receptor-active glucagon compounds
|
|
CA2778890A1
(en)
|
2009-10-30 |
2011-05-05 |
Otsuka Chemical Co., Ltd. |
Glycosylated form of antigenic glp-1 analogue
|
|
CN102686607B
(zh)
|
2009-12-16 |
2014-10-29 |
诺沃—诺迪斯克有限公司 |
双酰化glp-1衍生物
|
|
US8703701B2
(en)
|
2009-12-18 |
2014-04-22 |
Indiana University Research And Technology Corporation |
Glucagon/GLP-1 receptor co-agonists
|
|
AR079344A1
(es)
|
2009-12-22 |
2012-01-18 |
Lilly Co Eli |
Analogo peptidico de oxintomodulina, composicion farmaceutica que lo comprende y uso para preparar un medicamento util para tratar diabetes no insulinodependiente y/u obesidad
|
|
AR079345A1
(es)
|
2009-12-22 |
2012-01-18 |
Lilly Co Eli |
Analogo peptidico de oxintomodulina
|
|
US8551946B2
(en)
|
2010-01-27 |
2013-10-08 |
Indiana University Research And Technology Corporation |
Glucagon antagonist-GIP agonist conjugates and compositions for the treatment of metabolic disorders and obesity
|
|
US9145451B2
(en)
|
2010-05-13 |
2015-09-29 |
Indiana University Research And Technology Corporation |
Glucagon superfamily peptides exhbiting G protein coupled receptor activity
|
|
JP6121323B2
(ja)
|
2010-05-13 |
2017-05-10 |
インディアナ ユニバーシティー リサーチ アンド テクノロジー コーポレーションＩｎｄｉａｎａ Ｕｎｉｖｅｒｓｉｔｙ Ｒｅｓｅａｒｃｈ Ａｎｄ Ｔｅｃｈｎｏｌｏｇｙ Ｃｏｒｐｏｒａｔｉｏｎ |
核内ホルモン受容体の活性を示すグルカゴンスーパーファミリーのペプチド
|
|
CA2802931C
(en)
*
|
2010-05-17 |
2016-10-04 |
Zhejiang Beta Pharma Inc. |
Novel glucagon like peptide analogs, composition, and method of use
|
|
AU2011268327B2
(en)
|
2010-06-16 |
2016-02-25 |
Indiana University Research And Technology Corporation |
Single chain insulin agonists exhibiting high activity at the insulin receptor
|
|
RU2580317C2
(ru)
|
2010-06-24 |
2016-04-10 |
Индиана Юниверсити Рисерч Энд Текнолоджи Корпорейшн |
Пептидные пролекарства, принадлежащие к суперсемейству амид-содержащих глюкагонов
|
|
CA2803164C
(en)
|
2010-06-24 |
2018-08-21 |
Indiana University Research And Technology Corporation |
Amide-based insulin prodrugs
|
|
CN102397558B
(zh)
*
|
2010-09-09 |
2013-08-14 |
中国人民解放军军事医学科学院毒物药物研究所 |
Exendin-4类似物的定位聚乙二醇化修饰物及其用途
|
|
WO2012054822A1
(en)
|
2010-10-22 |
2012-04-26 |
Nektar Therapeutics |
Pharmacologically active polymer-glp-1 conjugates
|
|
CN103384528B
(zh)
|
2010-11-24 |
2016-04-13 |
杜雷科特公司 |
生物可降解的药物递送组合物
|
|
HUE036066T2
(hu)
|
2010-12-16 |
2018-06-28 |
Novo Nordisk As |
GLP-1 agonistát és N-(8-(2-hidroxibenzoil)amino)kaprilsav sóját tartalmazó szilárd készítmények
|
|
PE20140186A1
(es)
|
2010-12-22 |
2014-02-13 |
Univ Indiana Res & Tech Corp |
Analogos de glucagon que presentan actividad de receptor de gip
|
|
CN102718858B
(zh)
*
|
2011-03-29 |
2014-07-02 |
天津药物研究院 |
胰高血糖素样肽-1类似物单体、二聚体及其制备方法与应用
|
|
CN102718868A
(zh)
*
|
2011-03-30 |
2012-10-10 |
上海华谊生物技术有限公司 |
定点单取代聚乙二醇化Exendin类似物及其制备方法
|
|
EP3225631B1
(en)
|
2011-04-12 |
2019-01-09 |
Novo Nordisk A/S |
Double-acylated glp-1 derivatives
|
|
CN102180963B
(zh)
*
|
2011-04-22 |
2014-06-25 |
中国药科大学 |
胰高血糖素样肽-1(glp-1)类似物及其应用
|
|
CN102766204B
(zh)
*
|
2011-05-05 |
2014-10-15 |
天津药物研究院 |
胰高血糖素样肽-1突变体多肽及其制备方法和其应用
|
|
CN102786590A
(zh)
*
|
2011-05-19 |
2012-11-21 |
江苏豪森药业股份有限公司 |
分枝型peg修饰的glp-1类似物及其可药用盐
|
|
JP6179864B2
(ja)
|
2011-06-22 |
2017-08-16 |
インディアナ ユニヴァーシティ リサーチ アンド テクノロジー コーポレイション |
グルカゴン／ｇｌｐ−１レセプタコ−アゴニスト
|
|
CN103748109A
(zh)
|
2011-06-22 |
2014-04-23 |
印第安纳大学研究及科技有限公司 |
胰高血糖素/glp-1受体共同激动剂
|
|
CN102321170B
(zh)
*
|
2011-09-14 |
2013-11-13 |
深圳翰宇药业股份有限公司 |
利拉鲁肽变构体及其缀合物
|
|
EP2780031B1
(en)
|
2011-11-17 |
2018-03-07 |
Indiana University Research and Technology Corporation |
Glucagon superfamily peptides exhibiting glucocorticoid receptor activity
|
|
US20140294977A1
(en)
|
2011-11-23 |
2014-10-02 |
Durect Corporation |
Radiation-Sterilized Biodegradable Drug Delivery Composition
|
|
US9573987B2
(en)
|
2011-12-20 |
2017-02-21 |
Indiana University Research And Technology Corporation |
CTP-based insulin analogs for treatment of diabetes
|
|
HRP20181447T1
(hr)
|
2012-03-22 |
2018-11-02 |
Novo Nordisk A/S |
Pripravci glp-1 peptida i njihova priprava
|
|
DK2827845T3
(en)
|
2012-03-22 |
2019-04-01 |
Novo Nordisk As |
COMPOSITIONS INCLUDING A PROCEDURE AND PREPARING THEREOF
|
|
CN112142855A
(zh)
|
2012-05-18 |
2020-12-29 |
爱德迪安（北京）生物技术有限公司 |
用于糖尿病治疗的蛋白、蛋白缀合物及其应用
|
|
WO2013189988A1
(en)
|
2012-06-20 |
2013-12-27 |
Novo Nordisk A/S |
Tablet formulation comprising a peptide and a delivery agent
|
|
EP2864351B1
(en)
|
2012-06-21 |
2016-08-10 |
Indiana University Research and Technology Corporation |
Glucagon analogs exhibiting gip receptor activity
|
|
CA2886228A1
(en)
|
2012-09-26 |
2014-04-03 |
Indiana University Research And Technology Corporation |
Insulin analog dimers
|
|
CN103087179A
(zh)
*
|
2012-11-30 |
2013-05-08 |
中国药科大学 |
长效化胰高血糖素样肽-1(glp-1)类似物及其应用
|
|
CN103087178A
(zh)
*
|
2012-11-30 |
2013-05-08 |
中国药科大学 |
长效化胰高血糖素样肽-1(glp-1)类似物及其应用
|
|
CN103087175A
(zh)
*
|
2012-11-30 |
2013-05-08 |
中国药科大学 |
新型长效化胰高血糖素样肽-1(glp-1)类似物及其应用
|
|
CN103087176A
(zh)
*
|
2012-11-30 |
2013-05-08 |
中国药科大学 |
长效化胰高血糖素样肽-1(glp-1)类似物及其应用
|
|
CN103087177A
(zh)
*
|
2012-11-30 |
2013-05-08 |
中国药科大学 |
一类长效化胰高血糖素样肽-1(glp-1)类似物及其应用
|
|
WO2014158900A1
(en)
|
2013-03-14 |
2014-10-02 |
Indiana University Research And Technology Corporation |
Insulin-incretin conjugates
|
|
MY172578A
(en)
|
2013-05-02 |
2019-12-03 |
Novo Nordisk As |
Oral dosing of glp-1 compounds
|
|
ES2646538T3
(es)
|
2013-06-20 |
2017-12-14 |
Novo Nordisk A/S |
Derivados de GLP-1 y sus usos
|
|
MX2015016875A
(es)
|
2013-07-04 |
2016-04-07 |
Novo Nordisk As |
Derivados de peptidos similares a peptido similar a glucagon 1 (glp-1) y sus usos.
|
|
AU2014359894B2
(en)
|
2013-12-06 |
2020-09-17 |
Baikang (Suzhou) Co., Ltd |
Bioreversable promoieties for nitrogen-containing and hydroxyl-containing drugs
|
|
JP6564369B2
(ja)
|
2013-12-09 |
2019-08-21 |
デュレクト コーポレイション |
薬学的活性剤複合体、ポリマー複合体、ならびにこれらを伴う組成物及び方法
|
|
EP3206710B1
(en)
|
2014-09-24 |
2020-05-06 |
Indiana University Research & Technology Corporation |
Incretin-insulin conjugates
|
|
ES2947409T3
(es)
|
2014-09-24 |
2023-08-08 |
Univ Indiana Res & Tech Corp |
Profármacos de insulina a base de amida lipídica
|
|
WO2016065052A1
(en)
|
2014-10-22 |
2016-04-28 |
Extend Biosciences, Inc. |
Insulin vitamin d conjugates
|
|
WO2016065042A1
(en)
|
2014-10-22 |
2016-04-28 |
Extend Biosciences, Inc. |
Therapeutic vitamin d conjugates
|
|
ES2739289T3
(es)
|
2014-11-27 |
2020-01-30 |
Novo Nordisk As |
Derivados de GLP-1 y sus usos
|
|
US20160151511A1
(en)
*
|
2014-12-02 |
2016-06-02 |
Antriabio, Inc. |
Proteins and protein conjugates with increased hydrophobicity
|
|
CN107108714B
(zh)
|
2014-12-17 |
2022-02-08 |
诺和诺德股份有限公司 |
Glp-1衍生物及其用途
|
|
CN107636009B
(zh)
|
2014-12-30 |
2021-04-16 |
韩美药品株式会社 |
具有改善的稳定性的胰高血糖素衍生物
|
|
WO2016196017A1
(en)
|
2015-06-04 |
2016-12-08 |
Antriabio, Inc. |
Amine pegylation methods for the preparation of site-specific protein conjugates
|
|
TWI713541B
(zh)
|
2015-06-30 |
2020-12-21 |
南韓商韓美藥品股份有限公司 |
升糖素衍生物及包含該衍生物之長效接合物之組成物
|
|
HUE059737T2
(hu)
*
|
2015-12-31 |
2022-12-28 |
Hanmi Pharm Ind Co Ltd |
Glükagon, GLP-1 és GIP receptor aktiváló tripla aktivátor
|
|
CN107266557B
(zh)
*
|
2016-04-06 |
2020-04-07 |
天津药物研究院有限公司 |
一种聚乙二醇修饰的胰高血糖素样肽-1类似物
|
|
PE20190355A1
(es)
|
2016-06-29 |
2019-03-07 |
Hanmi Pharm Ind Co Ltd |
Derivado de glucagon, conjugado del mismo, composicion que comprende el mismo y uso terapeutico del mismo
|
|
RS64643B1
(sr)
|
2018-02-02 |
2023-10-31 |
Novo Nordisk As |
Čvrste kompozicije koje sadrže glp-1 agonist i so n-(8-(2-hidroksibenzoil)amino)kaprilne kiseline i lubrikant
|
|
US20220056077A1
(en)
|
2018-12-04 |
2022-02-24 |
Københavns Universitet |
Dual agonist glp-1 and neurotensin fusion peptide
|
|
WO2020214012A1
(ko)
*
|
2019-04-19 |
2020-10-22 |
한미약품 주식회사 |
글루카곤, glp-1 및 gip 수용체 모두에 활성을 갖는 삼중 활성체 또는 이의 결합체를 포함하는 고지혈증 예방 또는 치료용 약학적 조성물 및 예방 또는 치료 방법
|
|
WO2020214013A1
(ko)
*
|
2019-04-19 |
2020-10-22 |
한미약품 주식회사 |
글루카곤, glp-1 및 gip 수용체 모두에 활성을 갖는 삼중 활성체 또는 이의 결합체의 고지혈증에 대한 치료적 용도
|
|
US20210187077A1
(en)
*
|
2019-12-23 |
2021-06-24 |
Idaho State University |
GLP-1 Agonist Conjugates for Sustained Glycemic Control
|
|
JP2025534350A
(ja)
|
2022-09-30 |
2025-10-15 |
エクステンド バイオサイエンシズ インコーポレーテッド |
長時間作用型副甲状腺ホルモン
|